The bill amends the "Opioid Liability Litigation Act" by updating definitions and provisions related to various settlement agreements arising from the multidistrict litigation (MDL) concerning opioid-related claims. New definitions are added for settlements with Allergan, Alvogen, Amneal, Apotex, Hikma, Indivior, Kroger, Mylan, Purdue, Sun, and Zydus, while existing definitions for CVS, Distributor, Janssen, Teva, Walgreens, and Walmart settlements are modified or removed. The bill also clarifies the meaning of "MDL" and introduces new terms for the settlements, ensuring that all relevant agreements are recognized in the context of the law.

Additionally, the bill establishes specific deadlines after which political subdivisions of the state are prohibited from commencing or maintaining actions related to the released claims defined in the various settlements. These deadlines range from January 1, 2021, for certain settlements to January 1, 2025, for others, including the Kroger, Purdue, Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus settlements. This structured timeline aims to provide clarity and finality regarding the legal recourse available to political subdivisions in relation to opioid litigation.

Statutes affected:
Senate Introduced Bill: 691.1672, 691.1673
As Passed by the Senate: 691.1672, 691.1673